|
2025
|
Invention
|
Cyclin-dependent kinase degraders and methods of use.
The present application provides bifunctio... |
|
|
Invention
|
Engineered bifunctional receptors and uses thereof.
Described in several example embodiments her... |
|
|
Invention
|
Methods for treatment selection for chronic lymphocytic leukemia (cll).
As described below, the ... |
|
|
Invention
|
Nucleic acid nanostructures crosslinked with oligolysine.
The present disclosure provides, in so... |
|
|
Invention
|
Compositions and methods for transient gene therapy with enhanced stability.
The present inventi... |
|
|
Invention
|
Methods of treating cancers dependent upon the alternative lengthening of telomeres (alt) pathway... |
|
|
Invention
|
Antibodies against cd99 and methods of use thereof. The treatment for pediatric solid tumor patie... |
|
|
Invention
|
Minor histocompatibility antigen markers associated with graft versus leukemia effect and uses th... |
|
|
Invention
|
Minor histocompatibility antigen markers associated with graft versus host disease and uses there... |
|
|
Invention
|
Divalent pyridopyrimidinone-based compounds as egfr inhibitors. The disclosure relates to compoun... |
|
|
Invention
|
Usp7 activators. The present invention provides USP7 activators of Formula (I): (I). |
|
|
Invention
|
Methods of detecting leukemia stem cells. Methods of detecting leukemia stem cells are provided h... |
|
|
Invention
|
Usp28 inhibitors. The present invention relates to compounds of Formula (I): (I) or a pharmaceuti... |
|
|
Invention
|
Bcl-w polypeptides and mimetics for treating or preventing chemotherapy-induced peripheral neurop... |
|
|
Invention
|
Universal early cancer diagnostics.
Methods for quantifying DNA methylation that may be utilized... |
|
2024
|
Invention
|
Use of ire1alpha-xbp1 signaling pathway biomarkers for modulating immune responses.
The present ... |
|
|
Invention
|
Kinase inhibition and degradation. Compounds, and pharmaceutically acceptable salts thereof, usef... |
|
|
Invention
|
Chemical matters for targeting histone acetyltransferase p300 (ep300) and creb-binding protein (c... |
|
|
Invention
|
Crbn molecular glue degraders and uses thereof. Disclosed herein are compounds that can degrade p... |
|
|
Invention
|
Combination therapies comprising antibody molecules to tim-3.
Combination therapies comprising a... |
|
|
Invention
|
High risk biomarkers for myeloma precursor disease progression and methods of use thereof.
Provi... |
|
|
Invention
|
Detection and classification of b-cell malignancies. There are provided methods for detecting and... |
|
|
Invention
|
Methods of treating cancer by detecting gen1 variation. A method of detecting one or more variant... |
|
|
Invention
|
Chimeric antigen receptors and methods of use thereof.
The present invention provides chimeric a... |
|
|
Invention
|
Systems and methods to detect digital t cell receptor interactions with presented antigens. Some ... |
|
|
Invention
|
Antibody-drug conjugates and methods of use. Antibody-drug conjugates and pharmaceutical composit... |
|
|
Invention
|
Methods, kits and systems for determining sarcomatoid differentiation of renal cell carcinoma and... |
|
|
Invention
|
Shp-1 agonists. The present invention provides SHP-1 agonists of Formula I. |
|
|
Invention
|
Methods for reprogramming cells and uses thereof. ex vivoex vivo method for epigenetically reprog... |
|
|
Invention
|
Treatment of solid tumors with implantable polymers with small molecules or cells. Disclosed are ... |
|
|
Invention
|
Treatment of solid tumors with implantable polymers with small molecules. Disclosed are implantab... |
|
|
Invention
|
Methods of predicting relapse post hematopoietic stem-cell transplantation and methods of treatme... |
|
|
Invention
|
Cd73 inhibitor and anti-cd38 agent combination therapy. The present disclosure relates to methods... |
|
|
Invention
|
Egfr covalent inhibition with macrocycles. The disclosure relates to macrocyclic compounds that a... |
|
|
Invention
|
Pyrazolopiperazine compounds. The present invention relates to 4,5,6,7-tetrahydropyrazolo[1,5-a]p... |
|
|
Invention
|
Methods of treating blood cancers. A method of treating a blood cancer comprising the administrat... |
|
|
Invention
|
Ganglioside gm2 as a target for cancer immunotherapy. The present disclosure provides composition... |
|
|
G/S
|
Active biochemical ingredients being biological molecules
for use in the manufacture of pharmace... |
|
2023
|
G/S
|
Active biochemical ingredients being biological molecules for use in the manufacture of pharmaceu... |
|
|
G/S
|
Reagents for scientific or medical research; reagents for diagnostic use, other than medical or v... |
|
|
Invention
|
Discovery of covalent egfr inhibitor through cysteine 775.
The disclosure relates to compounds t... |
|
|
Invention
|
Vectors combining anti-sickling beta-as3-globin with anti bcel11a shrnamir to treat beta-hemoglob... |
|
|
Invention
|
Genetically engineered b cells and methods of use thereof.
This invention is directed to genetic... |
|
|
Invention
|
The combination of macrophage-directed immunotherapy and targeted agents for treatment of cancer.... |
|
|
Invention
|
Compositions and methods of a high-throughput screen to identify compounds that alter macrophage-... |
|
|
Invention
|
Compounds and compositions for anitmalarial therapeutic and prophylactic use.
Malaria still affl... |
|
|
Invention
|
Epitope engineering of cell-surface receptors.
Genetically engineered hematopoietic cells such a... |
|
|
Invention
|
Methods for decreasing pathologic alpha-synuclein using agents that modulate fndc5 or biologicall... |
|
|
Invention
|
Methods and compositions for treating cancer.
Provided herein are methods and compositions for t... |
|
|
Invention
|
Substituted heterocyclic csnk1 inhibitors.
The invention relates to a compound represented by fo... |
|
|
Invention
|
Compositions and methods for inhibiting stag1 expression and uses thereof.
Described herein are ... |
|
|
Invention
|
Chemical targeting swi/snf related, matrix associated, actin dependent regulator of chromatin, su... |
|
2022
|
Invention
|
Ink4 tumor suppressor proteins mediate resistance to cdk4/6 kinase inhibitors.
The present discl... |
|
2020
|
G/S
|
Investment services, namely, capital investment services |
|
|
G/S
|
medical research services, medical research services in the field of cancer |
|
|
G/S
|
Charitable fundraising for promotion of public education and awareness of biomedical sciences res... |
|
|
G/S
|
Charitable fundraising for promotion of public education and
awareness of biomedical sciences re... |
|
|
G/S
|
charitable fundraising for promotion of public education and awareness of biomedical sciences res... |
|
|
G/S
|
Fund-raising services for biomedical sciences research, particularly with regard to the preventio... |
|
|
G/S
|
Fund-raising services for biomedical sciences research,
particularly with regard to the preventi... |
|
2019
|
G/S
|
Medical research in the field of prevention, diagnosis and treatment of cancer and AIDS; medical ... |
|
|
G/S
|
Medical research in the field of prevention, diagnosis and
treatment of cancer and aids; medical... |
|
|
G/S
|
Medical and scientific research services in the field of diagnosis and treatment of cancer and au... |
|
|
G/S
|
Medical and scientific research services; providing
information in the fields of medical and sci... |
|
|
G/S
|
medical and scientific research services; providing information in the fields of medical and scie... |
|
2018
|
G/S
|
providing multiple user access to a platform for providing risk analysis, prediction, treatment, ... |
|
2017
|
G/S
|
charitable fundraising services; charitable fundraising services by means of an ice cream festiva... |
|
|
G/S
|
clinical risk assessment services in the nature of genetic testing for medical purposes based on ... |
|
2014
|
G/S
|
Charitable fundraising services; charitable fundraising services by organizing, sponsoring and co... |
|
2013
|
G/S
|
Charitable fund raising services to raise money for cancer treatment center operations, cancer re... |
|
2012
|
G/S
|
Providing medical and scientific research information in the fields of clinical trials and cancer... |
|
|
G/S
|
Charitable fundraising services, namely, fundraising for promotion of public education and awaren... |
|
2009
|
G/S
|
Charitable fund raising services, namely, organizing and sponsoring golf tournaments to raise mon... |
|
2005
|
G/S
|
Charitable fundraising services, namely raising money for cancer treatment center operations, can... |
|
|
G/S
|
Charitable fund raising services, namely, organizing and sponsoring ice cream eating festivals to... |
|
|
G/S
|
Charitable fund raising services, namely, sponsoring co-branded license plates that are sold to r... |
|
2003
|
G/S
|
Reagents for scientific or medical research; Antibodies for use in medical research [ ; Diagnosti... |
|
2002
|
G/S
|
MEDICAL RESEARCH IN THE FIELD OF PREVENTION, DIAGNOSIS AND TREATMENT OF CANCER AND AIDS MEDICAL S... |
|
|
G/S
|
Fundraising for promotion of public education and awareness of biomedical sciences research, part... |
|
2000
|
G/S
|
Charitable and memorial fund raising services for biomedical research, particularly with regard t... |
|
1998
|
G/S
|
medical research and services in the field of prevention, diagnosis and treatment of cancer and AIDS |
|
1988
|
G/S
|
FUND-RAISING SERVICES FOR BIOMEDICAL SCIENCES RESEARCH, PARTICULARLY WITH REGARD TO THE PREVENTIO... |
